
The Vesteck Inc Endosuture Aneurysm Repair (ESAR) platform, Suture-Tight™, is revolutionizing the aneurysm repair space.
VESTECK, INC. has raised $354K in total funding. The most recent round was Series A.
VESTECK, INC. is headquartered in Carlsbad, CA.
The Vesteck Inc Endosuture Aneurysm Repair (ESAR) platform, Suture-Tight™, is revolutionizing the aneurysm repair space.
During EVAR/TEVAR abdominal aortic aneurysm repair, implanted endografts can migrate or develop Type 1a endoleaks at the proximal neck, leading to reinterventions.
Vesteck is developing Suture-Tight, an endovascular suturing device that secures the proximal neck of implanted endografts to the aorta to prevent migration.
The device is backed by a $1.98M NIH/NHLBI Direct-to-Phase-II SBIR grant to fund FDA IDE approval and a pivotal trial, and is led by a team with decades of experience developing more than twenty cardiovascular medical devices.
Vesteck was co-founded by Dr. John Edoga, a general surgeon who holds 42 patents, alongside CEO Joseph Rafferty.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.